1. Home
  2. Stocks
  3. Sparc Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Sun Pharma Advanced Research Company Share Price Sun Pharma Advanced Research Company

    Mid Cap
    ₹270.9
    -14.25 (-5%)
    26 April, 2024 04:04 BSE: 532872 NSE: SPARCISIN: INE232I01014

    Start SIP in Sun Pharma Advanced Research Company

    Start SIP

    Sun Pharma Advanced Research Company Performance

    Day Range

    • Low 271
    • High 284
    ₹ 270

    52 Week Range

    • Low 179
    • High 473
    ₹ 270
    • Open Price271
    • Previous Close285
    • Volume14322218

    Sun Pharma Advanced Research Company Share Price

    • Over 1 Month -28.11%
    • Over 3 Month -28.13%
    • Over 6 Month +21.86%
    • Over 1 Year +38.18%

    Sun Pharma Advanced Research Company Key Statistics

    P/E Ratio -24.2
    PEG Ratio 0.3
    Market Cap Cr 8,791
    Price to Book Ratio 17.1
    EPS -6.9
    Dividend 0
    Relative Strength Index 25.85
    Money Flow Index 14.93
    MACD Signal -5.26
    Average True Range 18.85
    Sun Pharma Advanced Research Company Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 14212448
    Operating Expenses Qtr Cr 116113126137
    Operating Profit Qtr Cr -103-91-102-90
    Depreciation Qtr Cr 3333
    Interest Qtr Cr 0000
    Tax Qtr Cr 0000
    Net Profit Qtr Cr -100-86-95-82
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 250
    Operating Expenses Annual Cr 453
    Operating Profit Annual in Cr -214
    Depreciation Cr 12
    Interest Annual Cr 8
    Tax Annual Cr 0
    Net Profit Annual Cr -223
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr -69
    Cash from Investing Activity Annual Cr -548
    Cash from Financing Annual Activity Cr 617
    Net Cash Flow Annual Cr -1
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 513
    Fixed Assets Annual Cr 133
    Total Non Current Assets Annual Cr 375
    Total Current Assets Annual Cr 455
    Total Assets Annual Cr 830
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 16
    ROE Annual % -43
    ROCE Annual % -33
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % -85
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 142124
    Operating Expenses Qtr Cr 116113126
    Operating Profit Qtr Cr -103-91-102
    Depreciation Qtr Cr 333
    Interest Qtr Cr 000
    Tax Qtr Cr 000
    Net Profit Qtr Cr -100-86-95
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin %
    Sign Up to Know More
    Invest in Sun Pharma Advanced Research Company

    Sun Pharma Advanced Research Company Technicals

    EMA & SMA

    Current Price
    ₹270.9
    -14.25 (-5%)
    pointer
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • ₹354.19
    • 50 Day
    • ₹361.86
    • 100 Day
    • ₹343.60
    • 200 Day
    • ₹308.23
    • 20 Day
    • ₹373.37
    • 50 Day
    • ₹368.15
    • 100 Day
    • ₹349.25
    • 200 Day
    • ₹292.61

    Sun Pharma Advanced Research Company Resistance and Support

    PIVOT
    ₹275.17
    Resistance
    First Resistance 279.43
    Second Resistance 287.97
    Third Resistance 292.23
    RSI 25.85
    MFI 14.93
    MACD Single Line -5.26
    MACD -21.31
    Support
    First Resistance 266.63
    Second Resistance 262.37
    Third Resistance 253.83

    Sun Pharma Advanced Research Company Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 15,513,265 770,854,138 49.69
    Week 3,210,230 164,877,403 51.36
    1 Month 1,067,733 65,676,283 61.51
    6 Month 1,539,617 49,668,033 32.26

    Sun Pharma Advanced Research Company Result Highlights

    Sun Pharma Advanced Research Company Synopsis

    NSE-Medical-Biomed/Biotech

    Sun Pharma Advanced is involved in the business activities of Scientific research and development. Company’s Total Operating Revenue is Rs. 238.78 Cr. and Equity Capital is Rs. 32.45 Cr. for the Year ended 31/03/2023. Sun Pharma Advanced Research Company Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L73100GJ2006PLC047837 and registration number is 047837.
    Market Cap 8,791
    Sales 107
    Shares in Float 11.03
    No of funds 92
    Yield
    Book Value 17.15
    U/D Vol ratio 0.4
    LTDebt / Equity
    Alpha 0.02
    Beta 1.35

    Sun Pharma Advanced Research Company

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 65.67%65.67%65.67%65.67%
    Mutual Funds 0.25%0.24%0.23%0.21%
    Insurance Companies
    Foreign Portfolio Investors 3.24%3.3%3.67%3.64%
    Financial Institutions/ Banks
    Individual Investors 16.11%16.09%15.9%16.13%
    Others 14.73%14.7%14.53%14.35%

    Sun Pharma Advanced Research Company Management

    Name Designation
    Mr. Dilip S Shanghvi Chairman & Non-Exe.Director
    Dr. T Rajamannar Non Executive Director
    Dr. Robert J Spiegel Independent Director
    Mr. Sudhir V Valia Non Executive Director
    Ms. Bhavna Doshi Independent Director
    Dr. Ferzaan Engineer Independent Director

    Sun Pharma Advanced Research Company Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Sun Pharma Advanced Research Company Corporate Action

    Date Purpose Remarks
    2024-02-05 Quarterly Results
    2023-11-06 Quarterly Results
    2023-08-07 Quarterly Results
    2023-05-22 Audited Results & Others To consider Fund Raising
    2023-02-13 Quarterly Results

    Sun Pharma Advanced Research Company MF Shareholding

    Name Amount(cr)
    Quant Small Cap Fund Growth 17,349
    Quant ELSS Tax Saver Growth 8,342
    Nippon India Nifty Smallcap 250 Index Fund Reg Gr 1,093
    Motilal Oswal Nifty 500 Fund Regular Growth 741
    SBI Nifty Smallcap 250 Index Fund Regular Growth 604

    Sun Pharma Advanced Research Company FAQs

    What is Share Price of Sun Pharma Advanced Research Company ?

    Sun Pharma Advanced Research Company share price is ₹270 As on 26 April, 2024 | 03:50

    What is the Market Cap of Sun Pharma Advanced Research Company ?

    The Market Cap of Sun Pharma Advanced Research Company is ₹8791.3 Cr As on 26 April, 2024 | 03:50

    What is the P/E ratio of Sun Pharma Advanced Research Company ?

    The P/E ratio of Sun Pharma Advanced Research Company is -24.2 As on 26 April, 2024 | 03:50

    What is the PB ratio of Sun Pharma Advanced Research Company ?

    The PB ratio of Sun Pharma Advanced Research Company is 17.1 As on 26 April, 2024 | 03:50

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.